[artículo] 
inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 255-258

Título :	Synthetic Δ-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia
Tipo de documento:	texto impreso
Autores:	Glenn Schwarcz, Autor ; Basawaraj Karajgi, Autor ; Richard McCarthy, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 255-258
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Hipótesis cannabinoide de la esquizofrenia, Estimulación endocannabinoide
Resumen:	We are reporting improvement of symptoms of schizophrenia in a small group of patients who received the cannabinoid agonist dronabinol (synthetic Δ-9-tetrahydrocannabinol). Before this report, cannabinoids had usually been associated with worsening of psychotic symptoms.
Link:	./index.php?lvl=notice_display&id=29506

[artículo] Synthetic Δ-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia [texto impreso] / Glenn Schwarcz, Autor ; Basawaraj Karajgi, Autor ; Richard McCarthy, Autor . - 2022 . - pp. 255-258.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 255-258

Palabras clave:	Hipótesis cannabinoide de la esquizofrenia, Estimulación endocannabinoide
Resumen:	We are reporting improvement of symptoms of schizophrenia in a small group of patients who received the cannabinoid agonist dronabinol (synthetic Δ-9-tetrahydrocannabinol). Before this report, cannabinoids had usually been associated with worsening of psychotic symptoms.
Link:	./index.php?lvl=notice_display&id=29506